792 related articles for article (PubMed ID: 18614402)
1. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.
Peters R; Beckett N; Forette F; Tuomilehto J; Clarke R; Ritchie C; Waldman A; Walton I; Poulter R; Ma S; Comsa M; Burch L; Fletcher A; Bulpitt C;
Lancet Neurol; 2008 Aug; 7(8):683-9. PubMed ID: 18614402
[TBL] [Abstract][Full Text] [Related]
2. A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.
Peters R; Beckett N; Nunes M; Fletcher A; Forette F; Bulpitt C
Drugs Aging; 2006; 23(1):83-92. PubMed ID: 16492072
[TBL] [Abstract][Full Text] [Related]
3. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
[TBL] [Abstract][Full Text] [Related]
4. Increased pulse pressure linked to dementia: further results from the Hypertension in the Very Elderly Trial - HYVET.
Peters R; Beckett N; Fagard R; Thijs L; Wang JG; Forette F; Pereira L; Fletcher A; Bulpitt C
J Hypertens; 2013 Sep; 31(9):1868-75. PubMed ID: 23743809
[TBL] [Abstract][Full Text] [Related]
5. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
Bulpitt C; Fletcher A; Beckett N; Coope J; Gil-Extremera B; Forette F; Nachev C; Potter J; Sever P; Staessen J; Swift C; Tuomilehto J
Drugs Aging; 2001; 18(3):151-64. PubMed ID: 11302283
[TBL] [Abstract][Full Text] [Related]
6. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over.
Warwick J; Falaschetti E; Rockwood K; Mitnitski A; Thijs L; Beckett N; Bulpitt C; Peters R
BMC Med; 2015 Apr; 13():78. PubMed ID: 25880068
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.
Cunningham EL; Todd SA; Passmore P; Bullock R; McGuinness B
Cochrane Database Syst Rev; 2021 May; 5(5):CD004034. PubMed ID: 34028812
[TBL] [Abstract][Full Text] [Related]
8. Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.
Peters R; Beckett N; Forette F; Tuomilehto J; Ritchie C; Walton I; Waldman A; Clarke R; Poulter R; Fletcher A; Bulpitt C
Int Psychogeriatr; 2009 Apr; 21(2):359-68. PubMed ID: 19250558
[TBL] [Abstract][Full Text] [Related]
9. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial.
Beckett N; Peters R; Tuomilehto J; Swift C; Sever P; Potter J; McCormack T; Forette F; Gil-Extremera B; Dumitrascu D; Staessen JA; Thijs L; Fletcher A; Bulpitt C;
BMJ; 2011 Jan; 344():d7541. PubMed ID: 22218098
[TBL] [Abstract][Full Text] [Related]
10. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.
Forette F; Seux ML; Staessen JA; Thijs L; Birkenhäger WH; Babarskiene MR; Babeanu S; Bossini A; Gil-Extremera B; Girerd X; Laks T; Lilov E; Moisseyev V; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Fagard R
Lancet; 1998 Oct; 352(9137):1347-51. PubMed ID: 9802273
[TBL] [Abstract][Full Text] [Related]
11. Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).
Peters R; Pinto E; Beckett N; Swift C; Potter J; McCormack T; Nunes M; Grimley-Evans J; Fletcher A; Bulpitt C
Age Ageing; 2010 Jul; 39(4):439-45. PubMed ID: 20497949
[TBL] [Abstract][Full Text] [Related]
12. Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project.
Bulpitt CJ; Beckett N; Peters R; Staessen JA; Wang JG; Comsa M; Fagard RH; Dumitrascu D; Gergova V; Antikainen RL; Cheek E; Rajkumar C
Hypertension; 2013 Jan; 61(1):89-94. PubMed ID: 23172934
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).
Bulpitt CJ; Beckett NS; Peters R; Leonetti G; Gergova V; Fagard R; Burch LA; Banya W; Fletcher AE
J Hum Hypertens; 2012 Mar; 26(3):157-63. PubMed ID: 21390056
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in patients 80 years of age or older.
Beckett NS; Peters R; Fletcher AE; Staessen JA; Liu L; Dumitrascu D; Stoyanovsky V; Antikainen RL; Nikitin Y; Anderson C; Belhani A; Forette F; Rajkumar C; Thijs L; Banya W; Bulpitt CJ;
N Engl J Med; 2008 May; 358(18):1887-98. PubMed ID: 18378519
[TBL] [Abstract][Full Text] [Related]
15. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Patel A; ; MacMahon S; Chalmers J; Neal B; Woodward M; Billot L; Harrap S; Poulter N; Marre M; Cooper M; Glasziou P; Grobbee DE; Hamet P; Heller S; Liu LS; Mancia G; Mogensen CE; Pan CY; Rodgers A; Williams B
Lancet; 2007 Sep; 370(9590):829-40. PubMed ID: 17765963
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
Chalmers J; Castaigne A; Morgan T; Chastang C
J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
[TBL] [Abstract][Full Text] [Related]
17. Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.
Arima H; Anderson C; Omae T; Woodward M; Hata J; Murakami Y; Macmahon S; Neal B; Chalmers J;
Stroke; 2011 Aug; 42(8):2339-41. PubMed ID: 21700945
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension.
Kang S; Wu YF; An N; Ren M
Clin Ther; 2004 Feb; 26(2):257-70. PubMed ID: 15038948
[TBL] [Abstract][Full Text] [Related]
19. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
[TBL] [Abstract][Full Text] [Related]
20. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease.
McGuinness B; Todd S; Passmore P; Bullock R
Cochrane Database Syst Rev; 2006 Apr; (2):CD004034. PubMed ID: 16625595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
